The Biochemistry and Broad Utility of Pfizer’s New COVID-19 Drug: Paxlovid
A photo of a Pfizer facility in Italy. (Image Source: Dr. János Korom, Wikimedia Commons) On November 5th, 2021, Pfizer announced that it would seek FDA approval for its new drug, called Paxlovid. It is given to those with an active case of COVID-19 and has been shown to reduce the risk of hospitalization and …
The Biochemistry and Broad Utility of Pfizer’s New COVID-19 Drug: Paxlovid Read More »